# Safety and Efficacy of Autologous Cultured Adipocytes in Patient With Depressed Scar

> **NCT00992147** · PHASE2,PHASE3 · COMPLETED · sponsor: **Anterogen Co., Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Depressed Scar

## Interventions

- **DRUG:** Adipocell

## Key facts

- **NCT ID:** NCT00992147
- **Lead sponsor:** Anterogen Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2009-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00992147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00992147, "Safety and Efficacy of Autologous Cultured Adipocytes in Patient With Depressed Scar". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00992147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*